维普期刊资源整合服务平台（V6.5）

119篇 您的检索式：作者名="Jackman DM"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Phase II clinical trial of chemotherapy - naive patients ≥ 70years of age treated with erlotinib for advanced non - small - cell lung cancer 显示文摘	Jackman DM Yeap BY Lindeman NI	2007	J Clin Oncol2007，25，：	1
2	Response and resistance in a non-small-cell lung cancer patient with an epi- dermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib显示文摘	Jackman DM Holmes AJ Lindeman N	2006	J Clin Oncol2006，24，27：	1
3	Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients : results of an online tumor registry of clinical trials显示文摘	Jackman DM Miller VA Cioffredi LA	2009	Clin Cancer Res2009，15，16：	1
4	Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non - small cell lung cancer patients :results of an online tumor registry of clini- cal trials显示文摘	Jackman DM	2009	Clin Cancer Res2009，15，16：	1
5	Phase II clinical trial of chemotherapy-naive patients>or70 years of age treated with erlotinib for advanced non-small-cell lung cancer显示文摘	Jackman DM Yeap BY Ni LM	2007	J Clin Oncol2007，25，7：	1
6	Atypical ductal hyper-plasia:can some lesions be defined as probably benign after stereotactic 1 1-gauge vacuum-aseisted biopsy,eliminating the recommendation for surgical excision显示文摘	Jackman RJ Birdwell RL Ikeda DM		0，，02：	1
7	Phase II clinical trial of chemotherapy-naive patients > 70 years of age treated with erlotinib for advanced non small-cell lung cancer显示文摘	Jackman DM Yeap BY Lindeman NI	2007	J Clin Oneol2007，25，7：	1
8	Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in nonsmall cell lung cancer patients treated with gefitinib or erlotinib显示文摘	Jackman DM Yeap BY Sequist LV		0，，13：	1
9	Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma显示文摘	Jackman DM Kindler HL Yeap BY		0，，4：	1
10	Nomogram to predict the presence of EGFR activating mutation in lung Adenocarcinoma显示文摘	Girard N Sima SC Jackman DM		0，，02：	1
11	Phase II trial of erlotinib in chemotherapy - naive women with advanced pulmonary adenocarcinoma显示文摘	Jackman DM Cioffredi L Lindeman NI	2009	J Clin Oncol2009，27，15：	1
12	Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib显示文摘	Jackman DM Yeap BY Sequist LV	2006	Clin Cancer Res2006，12，13：	1
13	Small-cell lung cancer 显示文摘	Jackman DM Johnson BE	2005	Lancet2005，366，9494：	1
14	Delay of chemotherapy through use of post-progression Erlotinib in patients with EGFR-mutant lung cancer显示文摘	Oxnard GR Lo P Jackman DM		0，，15：	1
15	Small-cell lung cancer 显示文摘	Jackman DM Johnson BE	2005	Lancet2005，366，9494：	1
16	Phase Ⅱ clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for untreated advanced non-small cell cancer(NSCLS) :an analysis of life and symptom response显示文摘	Jackman DM Yeap BY Lindeman NI	2007	J Clin Oncol2007，25，7：	1
17	Impact of EGFR and KRAS genotype on outcomes in a clinical trial registry of NSCLC patients initially treated with erlotinib or gefitinib 显示文摘	Jackman DM Cioffredi L Sequist LV	2008	J Clin Oncol2008，26，15：	1
18	Impact of epidermalgrowth factor receptor and KRAS mutations on clinical outcomes inpreviously untreated non-small cell lung cancer patients: results ofan online tumor registry of clinical trials 显示文摘	Jackman DM Miller VA Ciofi&edi LA	2009	Clin Cancer Res2009，15，16：	1
19	Small-cell lung cancer 显示文摘	Jackman DM Johnson BE	2005	Lancet2005，366，9494：	1
20	Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor re- ceptor mutation and leptomeningeal metastases treated with high-dose gefitinib 显示文摘	Jackman DM Holmes A J Lindeman N	2006	J Clin Onco12006，24，27：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示